The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis

As a ligand-activated transcription factor, the aryl hydrocarbon receptor (AhR) is activated by structurally diverse ligands derived from the environment, diet, microorganisms, and metabolic activity. Recent studies have demonstrated that AhR plays a key role in modulating both innate and adaptive i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of autoimmunity 2023-07, Vol.138, p.103049-103049, Article 103049
Main Authors: Huang, Wei, Rui, Ke, Wang, Xiaomeng, Peng, Na, Zhou, Wenhao, Shi, Xiaofei, Lu, Liwei, Hu, Dajun, Tian, Jie
Format: Article
Language:English
Subjects:
Aryl hydrocarbon receptor
Autoimmune disease
Autoimmunity
Immune cell
Immunomodulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As a ligand-activated transcription factor, the aryl hydrocarbon receptor (AhR) is activated by structurally diverse ligands derived from the environment, diet, microorganisms, and metabolic activity. Recent studies have demonstrated that AhR plays a key role in modulating both innate and adaptive immune responses. Moreover, AhR regulates innate immune and lymphoid cell differentiation and function, which is involved in autoimmune pathogenesis. In this review, we discuss recent advances in understanding the mechanism of activation of AhR and its mediated functional regulation in various innate immune and lymphoid cell populations, as well as the immune-regulatory effect of AhR in the development of autoimmune diseases. In addition, we highlight the identification of AhR agonists and antagonists that may serve as potential therapeutic targets for the treatment of autoimmune disorders. [Display omitted] •The AhR signaling modulates the differentiation and function of innate immune cells and lymphoid cells.•Activation of AhR can regulate the development of autoimmune diseases.•AhR agonists and antagonists serve as potential therapeutic targets for the treatment of autoimmune disorders.
ISSN:0896-8411
1095-9157
DOI:10.1016/j.jaut.2023.103049